Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

The purpose of this clinical trial is to evaluate whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein improves biochemical and molecular markers, as well as clinical outcomes, in patients with liver disease related to chronic hepatitis C infection. The study will compare the investigational supplement with an active control (whey protein alone) to determine whether the combination formulation provides additional benefits on liver-related biomarkers and clinical assessment. Participants will: Take the investigational supplement or active control daily for 12 weeks. Attend clinic visits every 4 weeks for laboratory testing and clinical evaluations.

NCT Number	NCT07487623
Lead Sponsor	University of Guadalajara Collaborators: Hospital Civil de Guadalajara, Centro Universitario de Ciencias de la Salud, Mexico
Conditions	Liver Disease Chronic, HEPATITIS C VIRUS CHRONIC INFECTION
Enrollment	26 participants
Start Date	2025-10-11
Primary Completion	2026-03-31 (estimated)
Study Completion	2026-05-15 (estimated)
Updated on ClinicalTrials.gov	2026-03-23